Prospective analysis of both MRI PEER and CT PEER measurements for patients with known oncocytic neoplasm status and CD117 tumour staining on renal mass biopsy would be ideal, but this is limited as many patients may not proceed to nephrectomy for a gold standard reference for comparison. This evidence concerns the gene KIT and neoplasm.